백신 시장 규모, 점유율, 성장 분석, 기술별, 유형별, 적응 질환별, 투여 경로별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)

Global Vaccines Market size was valued at USD 72 billion in 2022 and is poised to grow from USD 74.66 billion in 2023 to USD 99.85 billion by 2031, growing at a CAGR of 3.70% during the forecast period (2024-2031).

The global vaccines market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and a heightened focus on healthcare. As medical technology evolves and investment in research and development of innovative vaccines intensifies, market players are likely to encounter new opportunities. The trend towards preventive healthcare is expected to foster greater vaccine adoption, supported by the introduction of new immunization programs and vaccine awareness initiatives. Furthermore, vaccination drives and advancements in vaccine technology will further enhance growth prospects for market participants over the forthcoming years. However, challenges such as widespread misinformation about vaccines, significant development costs, and strict regulatory requirements may hinder market progression. Overall, while the vaccines market is set to expand in response to global health challenges and growing awareness, stakeholders must navigate these obstacles to capitalize on the emerging opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vaccines Market Segmental Analysis

Global Vaccines Market is segmented by Technology, Type, Disease Indication, Route of Administration, End User, and region. Based on Technology, the market is segmented into Conjugate Vaccines, Recombinant Vaccines, Inactivated & Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Viral Vector Vaccines, MRNA Vaccines, and Other Vaccines. Based on Type, the market is segmented into Multivalent Vaccines, and Monovalent Vaccines. Based on Disease Indication, the market is segmented into Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, and Other Disease Indications. Based on Route of Administration, the market is segmented into Oral Route (PO), Intranasal Route (NAS), Subcutaneous Route (Subcut), Intramuscular Route (IM). Based on End User, the market is segmented into Adult Vaccines, and Pediatric Vaccines. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Vaccines Market

The surge in the incidence of infectious and chronic diseases globally has significantly heightened awareness regarding the importance of preventive healthcare, acting as a key market driver for the global vaccines market. As populations become more cognizant of the benefits associated with vaccination, the demand for effective and reliable vaccine solutions is set to rise. Vaccines not only help in thwarting the spread of diseases but also play a crucial role in alleviating healthcare burdens before they escalate into major health crises. Consequently, this increasing awareness and proactive health management are expected to catalyze substantial growth in vaccine sales across diverse demographics.

Restraints in the Global Vaccines Market

The Global Vaccines market faces a significant restraint due to the intricacies involved in vaccine development, which includes extensive clinical trials and comprehensive testing protocols. These processes are not only time-consuming but also entail substantial financial investments, leading to high development costs for vaccine manufacturers. Such economic burdens can deter smaller companies from entering the market or limit innovation, ultimately constraining the overall growth potential of the vaccines market. Additionally, the lengthy timelines required for regulatory approval further exacerbate the challenge, making it difficult for new vaccines to be introduced swiftly to address emerging health threats.

Market Trends of the Global Vaccines Market

The global vaccines market is experiencing a notable trend towards personalized vaccines, driven by the increasing demand for personalized medicine and advancements in healthcare technology. Companies are increasingly focusing on developing tailored vaccines that cater to individual patient profiles, thereby enhancing efficacy and improving overall health outcomes. This shift not only opens new avenues for vaccine providers but also aligns with evolving patient expectations for customized healthcare solutions. As the landscape of immunization evolves, the integration of personalized vaccination strategies is anticipated to revolutionize the market, presenting significant growth opportunities and fortifying the commitment to improved public health initiatives.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Technology Analysis
• Value Chain Analysis
• Patent Analysis
• Supply Chain Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Case Study Analysis
• Customer & Buying Criteria Analysis

Vaccines Market by Technology

• Market Overview
• Conjugate Vaccines
• Recombinant Vaccines
• Inactivated & Subunit Vaccines
• Live Attenuated Vaccines
• Toxoid Vaccines
• Viral Vector Vaccines
• MRNA Vaccines
• Other Vaccines

Vaccines Market by Type

• Market Overview
• Multivalent Vaccines
• Monovalent Vaccines

Vaccines Market by Disease Indication

• Market Overview
• Pneumococcal Disease
• Influenza
• Combination Vaccines
• HPV
• Meningococcal Disease
• Herpes Zoster
• Rotavirus
• MMR
• Varicella
• Hepatitis
• DTP
• Polio
• RSV
• Other Disease Indications

Vaccines Market by Route of Administration

• Market Overview
• Oral Route (PO)
• Intranasal Route (NAS)
• Subcutaneous Route (Subcut)
• Intramuscular Route (IM)

Vaccines Market by End User

• Market Overview
• Adult Vaccines
• Pediatric Vaccines

Vaccines Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• GSK Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK-Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt., Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panacea Biotec (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological E Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inovio Pharmaceuticals (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinovac (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incepta Pharmaceuticals Ltd. (Bangladesh)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VBI Vaccine Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Farma (Indonesia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microgen (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZHI FEI Biological (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments